Roche announced the official launch of the cobas® 5800 System, a new molecular laboratory instrument, in China.
The cobas 5800 System helps laboratories meet the challenges of increased patient testing, reimbursement complexities and the need for a more diverse test menu, while delivering meaningful and timely results.
The cobas 5800 System is a real-time PCR molecular testing solution that delivers superior performance and value in a compact footprint, offering automation, consolidation, integration and standardisation to provide a scalable, cost-effective solution for smaller laboratories seeking big lab performance or larger laboratories seeking small lab agility.
The system is designed to provide a fully automated workflow that includes sample delivery, transfer and preparation, amplification and detection, result calculation and delivery to the Laboratory Information System (LIS). The single module allows a walkaway time of up to eight hours, resulting in less hands-on time, which can lead to improved productivity, reduced opportunities for error and more predictable turnaround times.
To meet the unmet needs of clinics and patients and contribute to the development of China’s high-quality healthcare, we continue to promote the accelerated implementation of innovative solutions in China. The cobas 5800 system is the latest Roche Diagnostics solution in the field of molecular diagnostics with higher quality and faster speed, which is expected to help the majority of Chinese laboratories further enhance their molecular testing capabilities,” said Guoliang Yao (姚国樑), General Manager of Roche Diagnostics China.